Marshall Wace

Marshall Wace’s Fate Therapeutics FATE Stock Holding History

Marshall Wace’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,155	Closed	-$15.1K	–	2852
2025 Q1	$15.1K	Sell	19,155 -493,486	-96%	-$605K	﹤0.01%	2566
2024 Q4	$846K	Buy	+512,641	New	+$1.29M	﹤0.01%	1811
2024 Q3	–	Sell	-330,082	Closed	-$1.08M	–	2653
2024 Q2	$1.08M	Sell	330,082 -15,355	-4%	-$67.2K	﹤0.01%	1653
2024 Q1	$2.54M	Buy	+345,437	New	+$2.14M	﹤0.01%	1247
2022 Q1	–	Sell	-74,622	Closed	-$4.37M	–	3565
2021 Q4	$4.37M	Sell	74,622 -103,716	-58%	-$5.88M	0.01%	1464
2021 Q3	$10.6M	Buy	178,338 +127,195	+249%	+$9.98M	0.05%	524
2021 Q2	$4.44M	Buy	+51,143	New	+$4.12M	0.02%	915
2021 Q1	–	Sell	-68,278	Closed	-$6.21M	–	2592
2020 Q4	$6.21M	Buy	+68,278	New	+$4.24M	0.04%	495
2020 Q1	–	Sell	-16,273	Closed	-$318K	–	1762
2019 Q4	$318K	Buy	+16,273	New	+$258K	﹤0.01%	1261

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return